MAP Pharma (MAPP) Misses Q4 Views by 2c
- Market Wrap: Zimmer's Big Deal; Durable Orders Up...and Away!; UPS Slips on Winter Chill
- After-Hours Stock Movers 4/24: (CLH) (MKTO) (BIDU) Higher; (CAMP) (P) (CLF) Lower (more...)
- Microsoft Corp. (MSFT) Tops Q3 EPS by 5c
- Amazon.com, Inc. (AMZN) Reports In-Line Q1 EPS, Sales Beat
- Baidu.com (BIDU) Tops Q1 EPS by 25c; Issues Q2 Revs Outlook
MAP Pharmaceuticals, Inc. (NASDAQ: MAPP) reported Q4 loss of $0.46, 2 cents worse than the analyst estimate of ($0.44).
You May Also Be Interested In
- Hanesbrands (HBI) Tops Q1 EPS by 18c
- Barracuda Networks, Inc. (CUDA) Tops Q4 EPS by 5c
- Minerals Technologies Inc. (MTX) Tops Q1 EPS by 2c
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!